Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Pranger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|March 24, 2025
Factors influencing the learning experience in pharmaceutical internships: A qualitative interview studyR Abdolrahimi Raeni, A J de Beaufort, A D Pranger
Current Pharmaceutical Design|August 13, 2011
Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approachA D Pranger, J W C Alffenaar, R E Aarnoutse
Drugs|January 9, 2019
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019A D Pranger, T S van der Werf, J G W Kosterink, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 7, 2017
[Fatal intoxication with nicotine for e-cigarette]D H van der Meer, A D Pranger, I Jansen, et al.
The European Respiratory Journal|February 12, 2011
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experienceA D Pranger, R van Altena, R E Aarnoutse, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|March 24, 2025
Factors influencing the learning experience in pharmaceutical internships: A qualitative interview studyR Abdolrahimi Raeni, A J de Beaufort, A D Pranger
Current Pharmaceutical Design|August 13, 2011
Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approachA D Pranger, J W C Alffenaar, R E Aarnoutse
Drugs|January 9, 2019
The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019A D Pranger, T S van der Werf, J G W Kosterink, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 7, 2017
[Fatal intoxication with nicotine for e-cigarette]D H van der Meer, A D Pranger, I Jansen, et al.
The European Respiratory Journal|February 12, 2011
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experienceA D Pranger, R van Altena, R E Aarnoutse, et al.
Pageof 1